Built with thought-leaders at Sanofi, Eisai, AbbVie and Denali, the inaugural NIDD Summit will share the field’s cutting-edge scientific advances enabling you to translate your neuroimmunology research into a clinically effective therapeutic for neurological diseases.
With an emphasis on neurodegeneration, chronic neuroinflammatory mechanisms will be explored whilst addressing your drug development challenges:
- Discover robust biomarkers of neuroinflammation to enable successful translation and patient stratification
- Navigate preclinical model limitations to better predict clinical efficacy
- Explore the identification and validation of neuroimmunological targets and assess novel therapeutic approaches
Don’t miss this opportunity to learn from 20+ industry expert speakers to effectively target neuroimmunological mechanisms and rapidly progress your research to the clinic.
For more information, visit www.neuroimmunology-drugdevelopment.com